Physician profile
J Kyle Mathews
NPI 1730379934
$3,100.34
in general payments reported to CMS, 2019-2025
17 companies · $19.84 in 2025
The $19.84 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $266 · 2021: $104 · 2022: $1,697 · 2023: $207 · 2024: $174 · 2025: $19.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lina Medical USA INC | $1,055.55 | 2022 | |
| Coloplast Corp | $440.36 | 2019 | |
| Baxter Healthcare | $439.76 | 2022 | |
| Astellas Pharma US INC | $316.24 | 2019-2024 | Veozah, Myrbetriq |
| Axonics, INC. | $207.72 | 2020-2024 | Bulkamid, Axonics |
| Medtronic USA, INC. | $153.73 | 2019-2020 | |
| Pfizer INC. | $136.45 | 2019-2022 | |
| Femselect INC. | $97.51 | 2022-2024 | Enplace |
| Abbott Laboratories | $79.83 | 2023 | Diamondback Peripheral |
| Abbvie INC. | $44.42 | 2020-2023 | |
| Boston Scientific Corporation | $39.01 | 2019-2025 | General - Therapies |
| Myovant Sciences INC. | $19.51 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.08 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.79 | 2019 | |
| Integra Lifesciences Corporation | $13.06 | 2023 | Biodoptix, Biofix, Biodfactor |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $12.08 | 2019 | |
| Mission Pharmacal Company | $8.24 | 2024 | Uribel Tabs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J Mathews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.